Mostrar el registro sencillo

dc.contributor.authorBreviario, Silviaes_ES
dc.contributor.authorSenserrich Guerrero, Juliaes_ES
dc.contributor.authorFlorensa Zanuy, Eva Ariadna es_ES
dc.contributor.authorGarro Martínez, Emilioes_ES
dc.contributor.authorDíaz Martínez, Álvaro es_ES
dc.contributor.authorCastro Fernández, María Elena es_ES
dc.contributor.authorPazos Carro, Ángel es_ES
dc.contributor.authorPilar Cuéllar, María Fuencisla es_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-11-28T16:28:14Z
dc.date.available2022-11-28T16:28:14Z
dc.date.issued2023es_ES
dc.identifier.issn0278-5846es_ES
dc.identifier.issn1878-4216es_ES
dc.identifier.urihttps://hdl.handle.net/10902/26668
dc.description.abstractMajor depressive disorder is a highly prevalent psychiatric condition. Metalloproteinase 9 (MMP-9), a gelatinase involved in synaptic plasticity, learning and memory processes, is elevated in both chronic stress animal models and human peripheral blood samples of depressed patients. In this study we have evaluated the MMP-9 activity and protein expression in brain areas relevant to depression using the chronic corticosterone mouse model of depression. These mice show a depressive- and anxious-like behaviour. The MMP-9 activity and protein levels are significantly elevated in both the hippocampus and the cortex, and nectin-3 levels are lower in these brain areas in this model. In particular, these mice display an increased gelatinase activity in the CA1 and CA3 subfields of the hippocampus and in the internal layer of the prefrontal cortex. Moreover, the immobility time in the tail suspension test presents a positive correlation with the cortical MMP-9 activity, and a negative correlation with nectin-3 levels. In conclusion, the chronic corticosterone model of depression leads to an increase in the protein expression and activity of MMP-9 and a reduction of its substrate nectin-3 in relevant areas implicated in this disease. The MMP-9 activity correlates with behavioural despair in this model of depression. All these findings support the role of MMP-9 in the pathophysiology of depression, and as a putative target to develop novel antidepressant drugs.es_ES
dc.description.sponsorshipThis research was supported by the Ministerio de Ciencia, Innovación y Universidades (RTI2018-097534-B-I00) and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM).es_ES
dc.format.extent10 p.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights© 2022 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceProgress in neuro-psychopharmacology and biological psychiatry 120 (2023) 110624es_ES
dc.subject.otherMMP-9es_ES
dc.subject.otherCorticosterone modeles_ES
dc.subject.otherDepressiones_ES
dc.subject.otherCortexes_ES
dc.subject.otherHippocampuses_ES
dc.titleBrain matrix metalloproteinase-9 activity is altered in the corticosterone mouse model of depressiones_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1016/j.pnpbp.2022.110624es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1016/j.pnpbp.2022.110624es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International